Browsing by Author Ciruelos, Eva

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2015Adjuvant ovarian suppression in premenopausal breast cancerCoates, Alan; Bellet, Meritxell; Bonnefoi, Herve; Buchholz, Stefan; Burstein, Harold; Ciruelos, Eva; Climent, Miguel; Coleman, Richard; Colleoni, Marco; Da Prada, Gian; Davidson, Nancy; Fleming, Gini; Francis, Prudence; Gelber, Richard D. (Prof); Geyer, Charles; Giobbie-Hurder, Anita; Goldhirsch, Aron (Prof); Ingle, J.; Kerbrat, Pierre; Lang, Istvan; Maibach, Rudolph; Martino, Silvana; Price, K. N; Rabaglio-Poretti, Manuela; Regan, Meredith; Ruepp, Barbara; Viale, Giuseppe; Walley, Barbara; Winer, EP; School of Public Health: Public HealthAdjuvant ovarian suppression in premenopausal breast cancer, The New England Journal of Medicine, vol.372, 5, 2015,pp 436-446
2016Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trialCoates, Alan; Bellet, Meritxell; Bernhard, Jurg; Burstein, Harold J.; Ciruelos, Eva; et al, Various; Francis, Prudence; Lluch, Ana; Luo, Weixiu; Pavesi, Lorenzo; Ribi, Karin; School of Public Health: Public HealthAdjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trial, Journal of Clinical Oncology, vol.34, 14, 2016,pp 1601-1610
2016Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trialCoates, Alan; Bellet, Meritxell; Bernhard, Jurg; Burstein, Harold J.; Ciruelos, Eva; et al, Various; Francis, Prudence; Lluch, Ana; Luo, Weixiu; Pavesi, Lorenzo; Ribi, Karin; School of Public Health: Public HealthAdjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: Patient-reported outcomes in the suppression of ovarian function trial, Journal of Clinical Oncology, vol.34, 14, 2016,pp 1601-1610